148 related articles for article (PubMed ID: 6548939)
1. Plasma concentrations following single doses of morphine sulfate in oral solution and rectal suppository.
Ellison NM; Lewis GO
Clin Pharm; 1984; 3(6):614-7. PubMed ID: 6548939
[TBL] [Abstract][Full Text] [Related]
2. Prolonged release of morphine alkaloid from a lipophilic suppository base in vitro and in vivo.
Morgan DJ; McCormick Y; Cosolo W; Roller L; Zalcberg J
Int J Clin Pharmacol Ther Toxicol; 1992 Dec; 30(12):576-81. PubMed ID: 1473873
[TBL] [Abstract][Full Text] [Related]
3. Pharmacokinetic evaluation of ethionamide suppositories.
Peloquin CA; James GT; McCarthy E; Goble M
Pharmacotherapy; 1991; 11(5):359-63. PubMed ID: 1745621
[TBL] [Abstract][Full Text] [Related]
4. Difference in rectal absorption of morphine from hollow-type and conventional suppositories in rabbits.
Matsumoto Y; Watanabe Y; Yamamoto I; Matsumoto M
Biol Pharm Bull; 1993 Feb; 16(2):150-3. PubMed ID: 8364450
[TBL] [Abstract][Full Text] [Related]
5. [Morphine hydrochloride suppositories. II. Bioavailability of morphine hydrochloride suppositories in dogs].
Tan T; Kitamura K; Yamanaka M; Kojima K; Nakanishi Y; Arakawa S
Yakugaku Zasshi; 1990 Jun; 110(6):434-41. PubMed ID: 2213530
[TBL] [Abstract][Full Text] [Related]
6. The bioavailability of morphine in controlled-release 30-mg tablets per rectum compared with immediate-release 30-mg rectal suppositories and controlled-release 30-mg oral tablets.
Kaiko RF; Fitzmartin RD; Thomas GB; Goldenheim PD
Pharmacotherapy; 1992; 12(2):107-13. PubMed ID: 1570227
[TBL] [Abstract][Full Text] [Related]
7. Pharmacokinetics and clinical efficacy of rectal apomorphine in patients with Parkinson's disease: a study of five different suppositories.
van Laar T; Jansen EN; Neef C; Danhof M; Roos RA
Mov Disord; 1995 Jul; 10(4):433-9. PubMed ID: 7565822
[TBL] [Abstract][Full Text] [Related]
8. A comparison of salicylic acid levels in normal subjects after rectal versus oral dosing.
Maalouf R; Mosley M; James Kallail K; Kramer KM; Kumar G
Acad Emerg Med; 2009 Feb; 16(2):157-61. PubMed ID: 19076101
[TBL] [Abstract][Full Text] [Related]
9. Pharmacokinetics of tramadol and bioavailability of enteral tramadol formulations. 3rd Communication: suppositories.
Lintz W; Barth H; Osterloh G; Schmidt-Böthelt E
Arzneimittelforschung; 1998 Sep; 48(9):889-99. PubMed ID: 9793614
[TBL] [Abstract][Full Text] [Related]
10. [Morphine hydrochloride suppositories. I. Bioavailability of morphine hydrochloride suppositories in rats].
Tan T; Kojima K; Nakanishi Y; Arakawa S
Yakugaku Zasshi; 1990 Jun; 110(6):426-33. PubMed ID: 2213529
[TBL] [Abstract][Full Text] [Related]
11. Food interaction and steady-state pharmacokinetics of itraconazole oral solution in healthy volunteers.
Barone JA; Moskovitz BL; Guarnieri J; Hassell AE; Colaizzi JL; Bierman RH; Jessen L
Pharmacotherapy; 1998; 18(2):295-301. PubMed ID: 9545149
[TBL] [Abstract][Full Text] [Related]
12. [A patient with hepatoma and hepatic cirrhosis showing abnormally high blood morphine concentration after periodical suppository administration].
Kameue T; Matoba M; Ogawa H
Masui; 1994 Jan; 43(1):126-9. PubMed ID: 8309046
[TBL] [Abstract][Full Text] [Related]
13. Bioavailability of allopurinol oral and rectal dosage forms.
Chang SL; Kramer WG; Feldman S; Ballentine R; Frankel LS
Am J Hosp Pharm; 1981 Mar; 38(3):365-8. PubMed ID: 7223751
[TBL] [Abstract][Full Text] [Related]
14. Safety and effectiveness of intravenous morphine for episodic (breakthrough) pain using a fixed ratio with the oral daily morphine dose.
Mercadante S; Villari P; Ferrera P; Bianchi M; Casuccio A
J Pain Symptom Manage; 2004 Apr; 27(4):352-9. PubMed ID: 15050663
[TBL] [Abstract][Full Text] [Related]
15. Pharmacokinetics of promethazine hydrochloride after administration of rectal suppositories and oral syrup to healthy subjects.
Strenkoski-Nix LC; Ermer J; DeCleene S; Cevallos W; Mayer PR
Am J Health Syst Pharm; 2000 Aug; 57(16):1499-505. PubMed ID: 10965395
[TBL] [Abstract][Full Text] [Related]
16. Oral versus intravenous opioid dosing for the initial treatment of acute musculoskeletal pain in the emergency department.
Miner JR; Moore J; Gray RO; Skinner L; Biros MH
Acad Emerg Med; 2008 Dec; 15(12):1234-40. PubMed ID: 18945240
[TBL] [Abstract][Full Text] [Related]
17. Pharmacokinetics of oral morphine sulfate in dogs: a comparison of sustained release and conventional formulations.
Dohoo SE; Tasker RA
Can J Vet Res; 1997 Oct; 61(4):251-5. PubMed ID: 9342447
[TBL] [Abstract][Full Text] [Related]
18. Pharmacokinetics of an immediate and extended release oral morphine formulation utilizing the spheroidal oral drug absorption system in dogs.
Aragon CL; Read MR; Gaynor JS; Barnhart MD; Wilson D; Papich MG
J Vet Pharmacol Ther; 2009 Apr; 32(2):129-36. PubMed ID: 19290942
[TBL] [Abstract][Full Text] [Related]
19. Relative bioavailability of ondansetron 8-mg oral tablets versus two extemporaneous 16-mg suppositories: formulation and gender differences.
Jann MW; ZumBrunnen TL; Tenjarla SN; Ward ES; Weidler DJ
Pharmacotherapy; 1998; 18(2):288-94. PubMed ID: 9545148
[TBL] [Abstract][Full Text] [Related]
20. Pharmacokinetics of two novel rectal controlled-release morphine formulations.
Babul N; Darke AC; Anslow JA; Krishnamurthy TN
J Pain Symptom Manage; 1992 Oct; 7(7):400-5. PubMed ID: 1484193
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]